Cenkos Securities is an independent specialist securities firm focused on UK small and mid-cap companies.

They aim to be entrepreneurial, whilst seeking to establish long-term relationships with corporate and institutional clients.

Their directors and partners have on average more than 25 years' experience in the UK securities market. They have pioneered and led some of the most successful and innovative transactions in the UK securities market over the last decades.

AJ Bell Youinvest is a multi-award winning provider of SIPPs, stocks and shares ISAs, Junior ISAs, Junior SIPPs and share dealing accounts. We offer customers access to a market leading range of investment options, including: shares, funds, ETFs, investment trusts and much more. Our online dealing service starts from just £4.95 and never costs more than £9.95 per deal.

Shares is the leading weekly publication for the serious private investor. Full of forward facing actionable content, industry leading insight plus honest unbiased content; each week covering areas such as Stocks (Large, Mid or Small Cap), Commodities, Bonds, Funds, Forex, Spreadbetting, CFDs, ISAs, ETFs and personal investing.

Abzena provides a suite of complementary services and technologies to R&D organisations to improve the chances of successful development of therapeutic proteins and antibodies, and it is therefore poised to capitalise on the growth of the biopharmaceutical market. The Group has significant know-how, supported by a broad patent estate, to enable it to create better biopharmaceuticals for its customers.

Abzena operates a balanced business model with growing revenues from its service business and the potential for significant future growth through royalty bearing licences for the application of its technologies to biopharmaceutical products. The Group’s technologies and services are provided through its wholly-owned subsidiaries, PolyTherics and Antitope.

Portr is everyone’s personal on-demand porter service, placing less stressful luggage free journeys at travelers’ fingertips.

The service enables passengers to have their luggage delivered between London and it’s airports, same-day, whatever size, wherever they are, whenever needed. They are then free to travel around the city more efficiently, making the most of their time, without their burdensome baggage slowing them down, from only £25.

Combining security, transportation, B2B connectivity and consumer mobile accessibility through technology, Portr has achieved the aviation industry ambition of ‘seamless end-to-end passenger journeys’, delivering innovative solutions, helping airlines and airports improve passenger flows and generate ancillary revenue, while enhancing their travel experiences.  

Having launched at London City Airport in 2014, this year will see Portr’s rollout across a number of London airports.

APC Technology Group PLC provides technologies and services intended to help improve organisational sustainability.  These include sustainability consulting, energy reduction, energy generation, water management and project financing. It is also one of the UK’s leading distributors of specialist electronic components.

Since incorporation in 1982, we have developed outstanding relationships with both specialist manufacturers and our customers, who put significant value on our understanding of their individual business challenges and markets, our technical expertise and the high levels of customer service we provide.

For more than a decade, Atlantis has been actively involved in the commercialisation of tidal power technology and the development of tidal power projects around the world. Atlantis is striving to become the world’s leading developer of commercial scale tidal power projects and the technologies required to economically deliver tidal current power to the grid for sale and dispatch. Atlantis owns patented technologies covering power generation, turbine deployment and turbine operation and control. The combination of our technology and our track record in successful project origination and development, has created what we believe to be a uniquely commercial force in the marine power industry, able to develop and manage commercial-scale, marine power renewable energy projects globally.

The way businesses buy and sell services is being revolutionized. blur has torn up the old play book and replaced it with a new one where projects for talented, capable suppliers are won based on merit. We have nearly 50,000 service providers keen to impress you and successfully deliver your project - typically saving you 25%. Businesses like Amazon, Regus, Caterpillar and Argos have changed the way they buy and sell services. They find it easy, fast, fair, with better choice and guaranteed quality. You buy everything else online, why not business services?

Brady Plc is the largest European-headquartered provider of trading and risk management software to the global commodity, energy and recycling markets. Following our listing on AIM, Brady has achieved 50% compound annual growth in revenues over the past five years. It has entered new markets, developed new software solutions, and added global industry leaders as clients. Our growth has resulted from our strategy of combining organic growth with acquisitions, supported by Cenkos, our nomad and broker. Brady is the only UK stock exchange listed company active in the intersection of technology and commodities. We are ranked number one globally in metals, and US recycling, and are the energy Trading and risk Management solution provider with the most energy installations in Europe.

eg solutions is a back office workforce optimisation software company. eg pioneered this new market space and developed the most complete, purpose built workforce optimisation software for back offices – the only solution that manages work, people and end-to-end processes wherever they are undertaken, anywhere in the world.

Our software is used by leading UK, international and global companies in multiple industry sectors.

Using our forecasting, scheduling, real-time work management and operational analytics capabilities we deliver measureable improvements in service, quality, productivity and regulatory compliance. When supported by our implementation and training services we guarantee return on investment.

Eleco Plc is an AIM-listed software company with interests based principally in Sweden, Germany and the UK. Eleco develops software tools for the architectural, engineering and construction industries. Eleco is committed to promoting a more sustainable built environment by providing software and services that integrate the construction project delivery process from design through to delivery.

Escher Group Holdings plc is the world leading developer and provider of point of service software for use in the postal industry worldwide. Its core Riposte® software serves 35 national postal services across the world including the United States, Germany, Malaysia, South Africa and Saudi Arabia. The software enables post offices to expand upon their traditional offering, providing new revenue streams, reducing costs and increasing efficiency. The Group has also invested in new products such as Riposte TrEx which is designed to provide a national digital infrastructure linking governments, businesses and citizens via a secure platform. Escher has offices in Dublin, Boston, Singapore, Washington, London and Johannesburg. The Group had an initial public offering in 2011 and is listed on the London Alternative Investment Market (AIM).

Flowgroup's patented technology platform will help it dominate the global heating market and the emerging connected home space.

Flowgroup's product range launches with the world's first affordable electricity-generating boiler. This boiler generates low cost, low carbon electricity as it uses gas to heat a home.  It reduces customer electricity bills by 50% and household carbon emissions by up to 20%.  It's designed to become the leading domestic heating technology worldwide with a volume production price close to a standard boiler.

And there's even more to this game-changing boiler.  Couple its generation capability with internet connectivity and an intelligent thermostat and you have the beating heart of the smart, connected home - and a company with global prospects in the most exciting market around.

Imperial Innovations builds and invests in technology and healthcare companies based on the most promising technologies from our brightest scientists. It is connected with four of the world’s top research universities (Imperial, Cambridge, Oxford and UCL) which between them generate research income of £1.4 billion p.a. A significant technology investor with a portfolio of over 90 companies, Imperial Innovations has invested more than £176.0 million across its portfolio since 2006, and its companies have raised collectively investment of more than £822 million. Innovations invest in the most promising opportunities from whichever technology sector they arise and has built particular expertise in the key sectors of: Therapeutics, Medtech and devices, engineering and materials, and ICT.

Instem is a leading provider of IT applications to the global early development healthcare market. The Group is focused on the early development sector of the drug and chemical research and development industry, from late discovery and lead optimisation through to the Phase I clinical evaluation stage.

Instem’s Early Development Applications (EDA’s) are used in evaluation studies to:

- collect, analyse and report complex scientific data;- comply with regulatory reporting requirements;- improve quality, consistency and efficiency of information reporting; and- reduce the time of critical path R&D activities.

Instem’s solutions are supplied to an international blue chip customer base including AstraZeneca, GlaxoSmithKline and Charles River Laboratories.

Manx Telecom is the leading communication solutions provider on the Isle of Man. The Group offers a wide range of fixed line, broadband, mobile and data centre services to businesses, consumers and the public sector on the Isle of Man and provides a growing portfolio of innovative solutions to offshore customers through its Global Solutions division, including Strongest Signal Mobile roaming and Mobile Virtual Network Enabler Services (MVNE). It listed on the AIM section of the London Stock Exchange in February 2014, generated 2013 revenue of £76.0m, +5.0% yoy, and adjusted EBITDA of £27.5m, +11.5% yoy and intends to pay a full year 2014 dividend equivalent to a 7% yield on the IPO price of 142p per share.

MedaPhor is a global provider of advanced ultrasound education and training for medical professionals. Based in Cardiff in the UK and San Diego in the USA, our aim is simple – to build a world class ultrasound training company that has educational excellence as its core guiding principle.

That core principle is as important now as on the day we started. With products ranging from the very latest in advanced virtual-reality simulation training to hands-on postgraduate courses, we are committed to becoming the world’s leading ultrasound simulation company.

As an investment business providing funding, hands-on support and accommodation, Mercia's strategy is to provide seed, early stage and development capital from its third party funds under management (via its wholly owned subsidiary Mercia Fund Management) and, at a later stage, provide follow-on capital from its own resources to scale its emerging stars with the goal of realising value for shareholders through an exit over time. Operating nationally with a focus on the Midlands and the North, which have been historically underserved, Mercia has access to enviable sources of deal flow opportunities including partnerships held with nine universities in the region.

Plastics Capital is a specialist plastics products manufacturer focused on proprietary products for niche markets. The Group has five factories in the UK, two in China, one in Thailand and sales offices in the USA, Japan, India and China. Plastics Capital was listed on the AIM market in December 2007. 

Currently approximately 40 per cent of sales are exported to over 80 countries worldwide and production is concentrated in the UK where significant engineering know-how and automation underpins the Group’s competitiveness. 

The Group’s corporate strategy is to build shareholder value by continuing to grow its key businesses organically and through value enhancing acquisitions

Proxama is a global platform provider of proximity marketing, loyalty and contactless payment solutions on mobile. We provide proximity commerce solutions to financial institutions, media owners, retailers and brands.

Our two technology platforms, TapPoint® and CardGateway®, sit at the heart of our business. TapPoint® delivers proximity engagement and loyalty solutions for retailers, media owners and brands by utilising technologies such as NFC, Bluetooth LE (beacons), geo-fencing and QR codes. CardGateway® is our mobile contactless (NFC) payment platform that enables banks to transition their card portfolio onto mobile, for mobile contactless payments. 

We are a leading, clinical-stage stem cell business. Our primary objective is the development of novel stem cell therapies targeting areas of significant unmet or poorly met medical need.

We have used our unique stem cell technologies to develop cell-based therapies for significant disease conditions where the cells can be readily administered "off-the-shelf" to any eligible patient without the need for additional drug treatments. Our lead stem cell therapeutic candidate is a therapy for the treatment of patients left disabled by a stroke. Our second application for the CTX cells is for the treatment of critical limb ischaemia. Both treatments are currently in clinical development. Our hRPC stem cell candidate is for the treatment of retinitis pigmentosa, a blindness-causing desease of the retina. This treatment is in late pre-clinical development.

Rightster is a global b2b video network for distribution, content-sourcing, audience engagement and monetisation. Rightster’s software and services make it simple for sports, fashion, news, entertainment and viral rights holders to maximise the value of their video whether on a licenced, ad-funded, direct to consumer or paid placement basis. Rightster provides an “upload once – commercialise everywhere” solution that extends the reach of live and on-demand video content to web, mobile and connected audiences via clients’ own sites, social channels, portals, platforms, newspapers, magazines and specialist blogs. Thousands of syndication partners are already preconnected, and Rightster’s Multi channel network (MCN) on YouTube consists of 450 channels, regularly featuring in the comScore top partner rankings. Founded by Charlie Muirhead in May 2011, Rightster has since grown to approximately 200 employees across 11 offices in 10 countries.

At Rosslyn Analytics, we’re building intelligent businesses.  How?  By enabling our clients to prepare, manage and serve data to their business users.  But, not just any data.  We’re talking smart, enriched, analytics ready data.  With analytics ready data, decisions accelerate.  Teams collaborate.  People innovate.  Businesses captivate.

We’re focused solely on the complex business of data.  And, as business intelligence and analytics make the steady transition to the cloud, we’re taking an evolutionary rather than revolutionary approach.  An approach that bridges the all-important gap between business and data.  Which means data privacy, security and governance is assured. - See more at: http://www.rosslynanalytics.com/company/#sthash.6eCpkQzv.dpuf

SeaEnergy PLC (SEA.L) is an innovation-led offshore energy services business.  Since 2012, its focussed strategy has delivered significantly increased turnover, expanded its global reach and is moving towards profitability, in line with expectations.  It comprises:

ServicePower provides connected field services solutions that bring together the customer and the dispatch centre, technician, claims and warranty processes, parts, the contracted workforce, assets, mobility, business intelligence, and social collaboration. ServicePower connects all aspects of the field service value chain through the use of innovative technology that accelerates business efficiency gains and customer satisfaction while reducing costs. ServicePower is uniquely positioned to offer connected field services solutions on one underlying and consistent platform.

The SQS Group (SQS) is the world’s leading specialist in software quality. SQS’ position and expertise as the market leader are the result of over 30 years of successful consultancy. The company’s competitive edge stems mainly from its PractiQ methodology, which is based on many years of project experience and specialist knowledge across a wide range of industries. With over 7,000 completed projects, SQS has a strong customer base, including half of the DAX-30, almost a third of the STOXX-50 and 20 FTSE-100 companies. Our customers include Allianz, Beazley, BP, Centrica, Commerzbank, Daimler, Deutsche Post, Generali, JP Morgan, Meteor, Reuters, UBS and Volkswagen.  

Established over a century ago and headquartered in the UK, Stadium Group plc is an AIM listed, leading electronic technologies group with a turnover of circa £50 million and 800 employees.  Its diverse product portfolio includes power supplies, intelligent interface and displays (Human Machine Interface), M2M (Man-to-Machine) Wireless Connectivity solutions supporting the Internet of Things expansion and integrated electronic manufacturing services (iEMS), which it provides to a broad range of OEMs in the professional electronics market.

Stadium’s products are used in a wide variety of industries including industrial, medical, communications, green technology, automotive, marine, aviation, security and lighting.  It presently operates four manufacturing sites in the UK (Hartlepool, Warrington, Diss and Southampton) a low cost manufacturing operation in China (Dongguan), UK and Asia R&D Centres and commercial offices in the UK, Hong Kong and Australia.

TyraTech, Inc. was established in 2004 to utilize its novel technology to fill the unmet and increasing global demand for effective, safe, and natural pesticide technologies for human and animal health.

TyraTech's products incorporate a unique blend of potent natural active ingredients and are available in a number of markets including consumer, commercial, professional pest control, agriculture, human and animal health, vector control and livestock markets.

TyraTech, Inc. made its Initial Public Offering in June 2007 on the AIM section of the London Stock Exchange, where it trades under two separate common stock share listings (TYR and TYRU). Since going public, TyraTech has established partnerships with market leaders in areas such as human health as well as consumer and commercial pest control operators.

XLMedia is one of the largest independent online traffic providers to the gambling industry, delivering digital performance marketing services to over 120 operators. It attracts paying users from different online channels and directs them to online gambling operators, typically in return for a revenue share. XLMedia has a scalable platform and clear strategy to support significant growth in both new and existing markets.  With a track record of successful acquisitions it is also well positioned to act as an industry consolidator. In addition, XLMedia has a stated policy of returning at least 50% of retained earnings each year as dividends.

London Stock Exchange is the world's most international exchange. Nearly 2,500 companies from more than 90 countries are quoted across its markets, with a combined value of £4.4 trillion.

London Stock Exchange's markets include the Main Market - London's flagship venue for equity, debt and exchange traded products, offering businesses access to Europe's most liquid pool of capital - and AIM - the world's leading market for small and growing companies. Since its launch in 1995 AIM has helped 3,500 companies raise £87 billion.

Trading participants access London Stock Exchange markets via a range of secure, low latency interfaces, including the Order book for Retail Bonds (ORB), which since its launch in 2010 has allowed private investors to trade bonds in small denominations, and has helped companies raise over £4 billion.

London Stock Exchange also offers a range of real-time and reference data services, facilitating the trading and reporting of over £1 trillion of securities by 400 members annually.

London Stock Exchange is part of London Stock Exchange Group, which incorporates a range of pan-European trading, technology, post-trade and index businesses.

Instem is a robust and profitable provider of IT applications and technology enabled services to life sciences R&D.  Instem helps clients to bring life enhancing products to market faster, with the potential for significant return on their investment.

Instem’s solutions are essential to over 400 clients worldwide in areas such as:

· Collection, analysis and reporting of complex scientific data· Compliance with regulatory submission requirements, including the FDA-mandated SEND initiative· Improving quality, consistency and efficiency of critical R&D processes and corresponding information             reporting· Generating new scientific insights through identification, extraction and analysis of actionable information

Instem anticipates continued organic and acquisitive growth in a buoyant life sciences industry.

ReNeuron is a leading, clinical-stage cell therapy development business.  Based in the UK, its primary objective is the development of novel cell-based therapies targeting areas of significant unmet or poorly met medical need.  

ReNeuron has used its unique stem cell technologies to develop cell-based therapies for significant disease conditions where the cells can be readily administered “off-the-shelf” to any eligible patient without the need for additional immunosuppressive drug treatments.  The Company’s therapeutic candidates for stroke disability and critical limb ischaemia are in clinical development and its cell-based treatment for blindness-causing diseases of the retina is currently in pre-clinical development. 

ReNeuron is also advancing a proprietary platform technology to exploit nanoparticles (exosomes) secreted by stem cells as potential new drug candidates targeting indications in tissue repair, fibrosis and cancer.

Safestay PLC is the owner operator of a branded contemporary “boutique” hostel group. The first Hostel in the Elephant and Castle, London was opened in June 2012.The Safestay Business operates a new brand of contemporary hostel, designed to appeal to a broad range of guests. Known as a “boutique hostel” within the travel industry, it is aimed at providing safe, stylish accommodation which offers a more attractive alternative to both traditional hostels and budget hotel accommodation.

Aus­tralian Secu­ri­ties Exchange listed Scot­gold Resources Lim­ited (ASX:SGZ) was estab­lished in 2007 and listed on the ASX in Jan­u­ary 2008. The company’s shares were admit­ted to trad­ing on the AIM mar­ket of the Lon­don Stock Exchange (AIM:SGZ) in Feb­ru­ary 2010. The Company’s prin­ci­pal objec­tive, since 2008, has been the advance­ment of the Conon­ish Gold and Sil­ver Project in Scotland’s Grampian High­lands to a pro­duc­tion deci­sion and explo­ration of the highly prospec­tive ten­e­ments com­pris­ing the Grampian Gold Project with the view of iden­ti­fy­ing fur­ther project opportunities.

Valirx Plc is an oncology-focussed Biopharmaceutical Company, developing treatments and diagnostics. Technologies are selected by using rigorous clinical and commercial processes to address unmet market needs.

Clinical lead product is VAL201, a peptide for prostate cancer with follow-on indications in ovarian and breast cancers and endometriosis. Product VAL401, is a small molecule reformulation for lung cancers.

The Company’s proprietary technology platform, GeneICE, enables selective silencing of rebellious genes’ inappropriate activity. VAL101, the first GeneICE therapeutic, targets and reduces expression of Bcl-2, implicated in about half of cancers. GeneICE extension to neurology and inflammatory diseases will follow.

A novel diagnostic, the Nav3 system, detects pre-cancerous, cancerous and metastatic cells in tissue samples even before a tumour forms; indicating potential malignant formation.

Berkeley Energia Limited (BKY AIM/ASX) is a high impact, clean energy company focussed on bringing its wholly owned Salamanca project into production, commencing initial development in mid-2016.

The world class uranium project is being developed in an historic mining area in western Spain, about three hours west of Madrid. Following recent ministerial approval, the Company has now received all the European Union and National level approvals required for the initial development.

The project will generate measurable social and environmental benefits in the form jobs and skills training in a depressed rural community. It will also make a significant contribution to the security of supply of Europe’s zero carbon energy needs, where Euratom recently rated “lack of investment in new mines” as the number one risk facing European utilities.”

ReNeuron is a leading, clinical-stage cell therapy development business.  Based in the UK, its primary objective is the development of novel cell-based therapies targeting areas of significant unmet or poorly met medical need.  

ReNeuron has used its unique stem cell technologies to develop cell-based therapies for significant disease conditions where the cells can be readily administered “off-the-shelf” to any eligible patient without the need for additional immunosuppressive drug treatments.  The Company’s therapeutic candidates for stroke disability and critical limb ischaemia are in clinical development and its cell-based treatment for blindness-causing diseases of the retina is currently in pre-clinical development. 

ReNeuron is also advancing a proprietary platform technology to exploit nanoparticles (exosomes) secreted by stem cells as potential new drug candidates targeting indications in tissue repair, fibrosis and cancer.

Sphere Medical is a dynamic and growing company specialising in the development of innovative medical monitoring and diagnostic equipment. Their products are used in a wide range of medical applications, enabling faster clinical decision-making and improved patient outcomes, whilst providing efficiencies that result in reduced healthcare costs.

AJ Bell Youinvest is a multi-award winning provider of SIPPs, stocks and shares ISAs, Junior ISAs, Junior SIPPs and share dealing accounts. We offer customers access to a market leading range of investment options, including: shares, funds, ETFs, investment trusts and much more. Our online dealing service starts from just £4.95 and never costs more than £9.95 per deal.

BMR has successfully developed a proprietary acid/brine leach process that enables it to achieve high metal recoveries from the different tailings deposits.

BMR Group PLC is listed on AIM under the ticker BMR.

The Company is focused on the recovery of lead and zinc from the tailings deposits of Zambia’s oldest mine at Kabwe.

FreeAgent launched in 2007, hewn from the frustration that managing company finances was just too damn hard for most small businesses and freelancers. Since then we’ve doggedly stuck to our mantra of demystifying accounting and redefining the relationship people have with their finances.

ReNeuron is a leading, clinical-stage cell therapy development business.  Based in the UK, its primary objective is the development of novel cell-based therapies targeting areas of significant unmet or poorly met medical need.  

ReNeuron has used its unique stem cell technologies to develop cell-based therapies for significant disease conditions where the cells can be readily administered “off-the-shelf” to any eligible patient without the need for additional immunosuppressive drug treatments.  The Company’s therapeutic candidates for stroke disability and critical limb ischaemia are in clinical development and its cell-based treatment for blindness-causing diseases of the retina is currently in pre-clinical development. 

ReNeuron is also advancing a proprietary platform technology to exploit nanoparticles (exosomes) secreted by stem cells as potential new drug candidates targeting indications in tissue repair, fibrosis and cancer.

Tertiary Minerals plc (ticker symbol 'TYM') is an AIM-traded mineral exploration and development company building a significant strategic position in the fluorspar sector.

Vipera is a leading provider of mobile financial services platforms. The Vipera platform provides the easiest, fastest, most cost-effective way to develop and operate mobile data services. Solutions powered by Vipera run today on more than 500,000 phones, on hundreds of mobile networks in many countries. Founded in 2005, Vipera has offices in Zurich, Milan and London.